Bausch Health Companies Inc BHC:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/26/24 EDT
8.66quote price arrow down-0.05 (-0.57%)
Volume
15,359
Close
8.71quote price arrow up+0.09 (+1.04%)
Volume
2,066,045
52 week range
5.57 - 11.46
Loading...
  • Open8.62
  • Day High8.82
  • Day Low8.57
  • Prev Close8.62
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap3.194B
  • Shares Out366.67M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change8.6

KEY STATS

  • Open8.62
  • Day High8.82
  • Day Low8.57
  • Prev Close8.62
  • 52 Week High11.46
  • 52 Week High Date04/03/24
  • 52 Week Low5.57
  • 52 Week Low Date05/12/23
  • Market Cap3.194B
  • Shares Out366.67M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change8.6

RATIOS/PROFITABILITY

  • EPS (TTM)-1.62
  • P/E (TTM)-5.37
  • Fwd P/E (NTM)2.22
  • EBITDA (TTM)2.863B
  • ROE (TTM)-441.96%
  • Revenue (TTM)8.757B
  • Gross Margin (TTM)70.78%
  • Net Margin (TTM)-6.98%
  • Debt To Equity (MRQ)-2,190.61%

EVENTS

  • Earnings Date05/02/2024
  • Ex Div Date05/18/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Related Video

April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats up
VIDEO1:06:1001:06:10
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats up

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
BHC
Bausch Health Companies Inc
8.71+0.09+1.04%
GUD
CPH
HLS
RX
Biosyent Inc
8.51UNCHUNCH